Alexander Rialdi
Impact in
- Obstetrics and Gynecology top 5%
- Gestational Diabetes Research and Management
-
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- RNA Research and Splicing
- Protein Degradation and Inhibitors
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
Papers in
-
- Epigenetics and DNA Methylation 2
- Genomics and Chromatin Dynamics 2
- Receptor Mechanisms and Signaling 2
-
- Prostate Cancer Treatment and Research 2
- Co-authors
- Sven Heinz (1 shared paper)Adolfo García‐Sastre (1 shared paper)Max W. Chang (1 shared paper)Michael G.B. Hayes (1 shared paper)Lorane Texari (1 shared paper)Ivan Marazzi (1 shared paper)Christopher Benner (1 shared paper)Lars Pache (1 shared paper)
- Journals
- Cell Reports (2 papers)Progress in community health partnerships (2 papers)Molecular Cancer Therapeutics (1 paper)Nature Chemical Biology (1 paper)Cell (1 paper)
- Partner nations
- United StatesSpainPoland
In The Last Decade
Alexander Rialdi
11 papers receiving 702 citations
Peers
Comparison fields: 5 of 80
- Obstetrics and Gynecology 83
- Molecular Biology 504
- Pediatrics, Perinatology and Child Health 88
- Cancer Research 58
- Immunology 52
Countries citing papers authored by Alexander Rialdi
This map shows the geographic impact of Alexander Rialdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Rialdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Rialdi more than expected).
Fields of papers citing papers by Alexander Rialdi
This network shows the impact of papers produced by Alexander Rialdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Rialdi. The network helps show where Alexander Rialdi may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexander Rialdi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 288 | |
| 2 | 2019 | 175 | |
| 3 | 2013 | 139 | |
| 4 | 2013 | 27 | |
| 5 | 2019 | 18 | |
| 6 | 2014 | 17 | |
| 7 | 2022 | 15 | |
| 8 | 2023 | 12 | |
| 9 | 2022 | 12 | |
| 10 | 2013 | 3 | |
| 11 | 2021 | 2 |
About Alexander Rialdi
Alexander Rialdi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cell Biology and Cancer Research, having authored 11 papers that have together received 708 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (2 papers), Lung Cancer Research Studies (2 papers), Epigenetics and DNA Methylation (2 papers), Genomics and Chromatin Dynamics (2 papers), Receptor Mechanisms and Signaling (2 papers), Cancer Mechanisms and Therapy (1 paper), Gestational Diabetes Research and Management (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Obstetrics and Gynecology (83 citations), Molecular Biology (504 citations), Pediatrics, Perinatology and Child Health (88 citations), Cancer Research (58 citations) and Immunology (52 citations). Alexander Rialdi has collaborated with scholars based in United States, Spain and Poland. Frequent co-authors include Sven Heinz, Adolfo García‐Sastre, Max W. Chang, Michael G.B. Hayes, Lorane Texari, Ivan Marazzi, Christopher Benner, Lars Pache, Matthew Urbanowski and Randy A. Albrecht. Their work appears in journals such as Cell Reports, Progress in community health partnerships, Molecular Cancer Therapeutics, Nature Chemical Biology and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.